Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Employment agrmnt
Acq. announced
Consulting agrmnt
Inv. presentation

PROLOR Biotech, Inc. (PBTH) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/10/2013 EFFECT Form EFFECT - Notice of Effectiveness
09/09/2013 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
09/06/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
09/06/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
09/06/2013 POS AM Form POS AM - Post-Effective amendments for registration statement
09/03/2013 4 HAVRON ABRAHAM (CEO) has filed a Form 4 on PROLOR Biotech, Inc.
09/03/2013 4 STERN ADAM K (Director) has filed a Form 4 on PROLOR Biotech, Inc.
Txns: Disposed/sold 275,000 shares @ $0
Disposed/sold 10,000 options to buy @ $4.52, valued at $45.2k
Disposed/sold 40,000 options to buy @ $4.74, valued at $189.6k
09/03/2013 4 FARES FUAD (Director) has filed a Form 4 on PROLOR Biotech, Inc.
09/03/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
09/03/2013 4 GORECKI MARIAN (Director) has filed a Form 4 on PROLOR Biotech, Inc.
09/03/2013 4 Rubin Steven D (Director) has filed a Form 4 on PROLOR Biotech, Inc.
09/03/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
09/03/2013 4 NOVIK SHAI A (President) has filed a Form 4 on PROLOR Biotech, Inc.
08/30/2013 8-K Quarterly results
08/30/2013 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
08/09/2013 10-Q Quarterly Report for the period ended June 30, 2013
07/24/2013 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
07/15/2013 PRER14A Form PRER14A - Preliminary Proxy Soliciting materials
06/12/2013 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans
06/07/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/06/2013 4 HAVRON ABRAHAM (CEO) has filed a Form 4 on PROLOR Biotech, Inc.
06/06/2013 4 FROST PHILLIP MD ET AL (10% Owner) has filed a Form 4 on PROLOR Biotech, Inc.
Txns: Granted 542,000 options to buy @ $0
06/06/2013 4 FARES FUAD (Director) has filed a Form 4 on PROLOR Biotech, Inc.
06/06/2013 4 NOVIK SHAI A (President) has filed a Form 4 on PROLOR Biotech, Inc.
06/06/2013 4 HSIAO JANE PH D (Director) has filed a Form 4 on PROLOR Biotech, Inc.
Txns: Granted 40,000 options to buy @ $0
06/06/2013 4 GORECKI MARIAN (Director) has filed a Form 4 on PROLOR Biotech, Inc.
06/06/2013 4 Rubin Steven D (Director) has filed a Form 4 on PROLOR Biotech, Inc.
06/06/2013 4 STERN ADAM K (Director) has filed a Form 4 on PROLOR Biotech, Inc.
06/05/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
06/04/2013 8-K Other Events, Financial Statements and Exhibits
Docs: "PROLOR BIOTECH initiates PIVOTAL phase III trial of ITS Longer-Acting Version of human growth hormone Nes-Ziona, Israel– June 4, 2013 – PROLOR Biotech, Inc. , a company developing next-generation biobetter therapeutic proteins, today announced the initiation of a pivotal Phase III clinical trial of hGH-CTP, the company’ s proprietary version of human growth hormone , in growth hormone deficient adults. PROLOR is developing hGH-CTP to provide growth hormone deficient adults and children with hGH therapy that may require only once-weekly or bi-monthly injections, rather than the daily injections required by current hGH therapy. The initiation of the Phase III clinical trial follows a set of successful Phase II trials showing that hGH-CTP has the potential to be effective when injected once w..."
06/04/2013 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
05/30/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
05/29/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
05/10/2013 10-Q Quarterly Report for the period ended March 31, 2013
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy